Apyx Medical Corporation (APYX)
NASDAQ: APYX · Real-Time Price · USD
3.920
+0.080 (2.08%)
At close: Feb 18, 2026, 4:00 PM EST
3.930
+0.010 (0.26%)
After-hours: Feb 18, 2026, 4:10 PM EST

Apyx Medical Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
161599181440247
Market Cap Growth
222.32%-34.47%12.12%-81.61%78.41%-14.63%
Enterprise Value
175708367410204
Last Close Price
3.921.582.622.3412.827.20
PS Ratio
3.361.241.731.829.078.90
PB Ratio
25.354.153.372.148.153.86
P/TBV Ratio
27.504.193.402.158.203.87
EV/Sales Ratio
3.651.471.591.518.457.38
Debt / Equity Ratio
6.452.701.430.020.010.01
Net Debt / Equity Ratio
2.320.49-0.19-0.25-0.57-0.65
Net Debt / EBITDA Ratio
-1.58-0.380.270.422.262.15
Net Debt / FCF Ratio
-1.48-0.370.890.442.742.48
Asset Turnover
0.810.670.800.740.680.35
Inventory Turnover
1.972.141.711.662.762.24
Quick Ratio
3.474.414.542.413.956.47
Current Ratio
4.445.265.523.634.607.22
Return on Equity (ROE)
-168.13%-114.21%-58.26%-50.71%-25.79%-17.62%
Return on Assets (ROA)
-10.06%-16.35%-19.04%-24.18%-12.64%-15.80%
Return on Capital Employed (ROCE)
-20.50%-34.80%-30.00%-58.40%-26.00%-30.90%
Earnings Yield
-9.04%-39.45%-20.62%-28.64%-3.45%-4.82%
FCF Yield
-5.90%-31.56%-6.37%-26.30%-2.54%-6.75%
Buyback Yield / Dilution
-15.78%-2.66%-0.31%-0.54%-0.35%-0.42%
Updated Nov 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q